The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
- PMID: 18473732
- DOI: 10.2174/156800908784293659
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Abstract
PTEN/PI3K/AKT constitutes an important pathway regulating the signaling of multiple biological processes such as apoptosis, metabolism, cell proliferation and cell growth. PTEN is a dual protein/lipid phosphatase which main substrate is the phosphatidyl-inositol,3,4,5 triphosphate (PIP3), the product of PI3K. Increase in PIP3 recruits AKT to the membrane where it is activated by other kinases also dependent on PIP3. Many components of this pathway have been described as causal forces in cancer. PTEN activity is lost by mutations, deletions or promoter methylation silencing at high frequency in many primary and metastatic human cancers. Germ line mutations of PTEN are found in several familial cancer predisposition syndromes. Activating mutations which have been reported for PI3K and AKT, in tumours are able to confer tumourigenic properties in several cellular systems. Additionally, the binding of PI3K to oncogenic ras is essential for the transforming properties of ras. In summary, the data strongly support the view of the PTEN/PI3K/AKT pathway as an important _target for drug discovery.
Similar articles
-
The PKB/AKT pathway in cancer.Curr Pharm Des. 2010 Jan;16(1):34-44. doi: 10.2174/138161210789941865. Curr Pharm Des. 2010. PMID: 20214616 Review.
-
PTEN, more than the AKT pathway.Carcinogenesis. 2007 Jul;28(7):1379-86. doi: 10.1093/carcin/bgm052. Epub 2007 Mar 6. Carcinogenesis. 2007. PMID: 17341655 Review.
-
Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.Biochem J. 2005 Sep 1;390(Pt 2):613-23. doi: 10.1042/BJ20050574. Biochem J. 2005. PMID: 15913452 Free PMC article.
-
PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.Oncol Rep. 2009 Mar;21(3):731-5. Oncol Rep. 2009. PMID: 19212633
-
PI3K/PTEN signaling in tumorigenesis and angiogenesis.Biochim Biophys Acta. 2008 Jan;1784(1):150-8. doi: 10.1016/j.bbapap.2007.09.008. Epub 2007 Sep 29. Biochim Biophys Acta. 2008. PMID: 17964232 Review.
Cited by
-
MUFFINN: cancer gene discovery via network analysis of somatic mutation data.Genome Biol. 2016 Jun 23;17(1):129. doi: 10.1186/s13059-016-0989-x. Genome Biol. 2016. PMID: 27333808 Free PMC article.
-
Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies.Nutrients. 2024 Jun 14;16(12):1883. doi: 10.3390/nu16121883. Nutrients. 2024. PMID: 38931238 Free PMC article. Review.
-
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.J Biol Chem. 2012 Aug 31;287(36):30228-39. doi: 10.1074/jbc.M112.343947. Epub 2012 Jun 27. J Biol Chem. 2012. PMID: 22740693 Free PMC article.
-
Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.Int J Biochem Mol Biol. 2015 Mar 20;6(1):1-16. eCollection 2015. Int J Biochem Mol Biol. 2015. PMID: 26045972 Free PMC article.
-
Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents.Onco_target. 2017 Jan 24;8(4):7181-7200. doi: 10.18632/onco_target.12742. Onco_target. 2017. PMID: 27769061 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials